UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048447
Receipt number R000055195
Scientific Title Survey of hypoglycemia unawareness using CGM in type 2 diabetes with high risk of severe hypoglycemia
Date of disclosure of the study information 2022/07/26
Last modified on 2022/07/22 14:26:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey of hypoglycemia unawareness using CGM in type 2 diabetes with high risk of severe hypoglycemia

Acronym

Hypoglycemia unawareness using CGM in type 2 diabetes

Scientific Title

Survey of hypoglycemia unawareness using CGM in type 2 diabetes with high risk of severe hypoglycemia

Scientific Title:Acronym

Hypoglycemia unawareness using CGM in type 2 diabetes

Region

Japan


Condition

Condition

Type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In patients with type 2 diabetic who are at high risk of severe hypoglycemia, we clarify the clinical characteristics of cases that cause hypoglycemia, and use CGM to determine the time zone when hypoglycemia occurs frequently and glucose profile even if it does not become severe.

Basic objectives2

Others

Basic objectives -Others

We evaluate the relationship between CGM data and medical information (age, height, weight, gender, duration, complications such as retinopathy, nephropathy, neuropathy, hypertension, dyslipidemia, HbA1c, eGFR).

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Time below range (level 1; glucose < 56 mg/dL, and 2; glucose < 54 mg/dL) during whole day, day time and night time.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Type 2 diabetes with high risk of severe hypoglycemia: 65 years or older, HbA1c <7.5%, treatment with Sulfonyl Urea or insulin.
Supplement: Decreased renal function (eGFR <60 ml / min / 1.73 m2), history of severe hypoglycemia, It is even more desirable if there is hypoglycemia unawareness.

Key exclusion criteria

Current treatment with CGM.
Skin trouble due to CGM in the past

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Munehide
Middle name
Last name Matsuhisa

Organization

Tokushima University

Division name

Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences

Zip code

770-8503

Address

3-18-15 Kuramoto-cho, Tokushima City, Tokushima

TEL

0886337587

Email

matuhisa@tokushima-u.ac.jp


Public contact

Name of contact person

1st name Munehide
Middle name
Last name Matsuhisa

Organization

Tokushima University

Division name

Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences

Zip code

770-8503

Address

3-18-15 Kuramoto-cho, Tokushima City, Tokushima

TEL

0886337587

Homepage URL


Email

matuhisa@tokushima-u.ac.jp


Sponsor or person

Institute

Japan Diabetes Society

Institute

Department

Personal name



Funding Source

Organization

Japan Diabetes Society

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

the ethical committee at the Japan Diabetes Society

Address

Wajyun Bild. 2F, 2-22-2 Koishikawa, Bunkyo-ku, Tokyo

Tel

03-3815-4364

Email

harada@jds.or.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

4118

Org. issuing International ID_1

Ethical committee at the Tokushima University Hospital,

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

徳島大学病院他 80施設


Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 04 Month 14 Day

Date of IRB

2021 Year 04 Month 14 Day

Anticipated trial start date

2022 Year 07 Month 27 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Non-invasive clinical trials


Management information

Registered date

2022 Year 07 Month 25 Day

Last modified on

2022 Year 07 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055195


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name